This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Nucleic Acid Testing Market

Market Insights on Nucleic Acid Testing covering sales outlook, demand forecast & up-to-date key trends

Nucleic Acid Testing Market by Product Type (Nucleic Acid Test Kits, Consumables), Indication (Infectious Diseases, Cancer, Forensic Testing), End-User (Hospitals, Pathology Laboratories, Research Institutes, Clinics), and Region for 2022 - 2028

Nucleic Acid Testing Market Outlook 2022-2028

[333 Pages Report] Sales in the global Nucleic Acid Testing Market are slated to top US$ 3.4 Bn in 2022. Expanding at a healthy 7.3% CAGR, the market size is projected to total US$ 5.25 Bn by 2028.

Attribute

Details

Nucleic Acid Testing Estimated Market Size 2022

US$ 3.4 Bn

Nucleic Acid Testing Market Value-based CAGR (2022-2028)

~7.3%

Nucleic Acid Testing Market Projected Size in 2028

US$ 5.25 Bn

The urgent need to trace communicable diseases with the surging prevalence of COVID-19 in various parts of the world is likely to propel the sales in the nucleic acid testing market. These tests are capable of detecting the ribonucleic acid (RNA) sequences that include the genetic material of the coronavirus.

Since the beginning of the pandemic, the U.S. Food and Drug Administration (FDA) has increased both the types and number of nucleic acid tests for emergency use for the detection of SARS-CoV-2. In the near future, other government organizations are expected to authorize more such tests for the early detection and prevention of this disease.

Increasing investment by government and private agencies in the development of novel biotechnological diagnostic techniques and high demand for technologically advanced diagnostic measures are projected to bolster the growth in the nucleic acid testing market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

7.48%

H1, 2022 Projected

7.29%

H1, 2022 Outlook

6.69%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 60 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 79 ↓

The comparative analysis and market growth rate of nucleic acid testing market as studied by Future Market Insights, expects to show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 60 BPS, and, a decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 79 Basis Point Share (BPS).

Some approaches associated with nucleic acid testing are time-consuming, expensive, technically challenging, and not user-friendly, which are some of the factors contributing to the decline in BPS values.

The need for integrated systems with digitally improved data point displays with diagnostic patterns for identified pathogenesis arises from the inability of multiple devices to take into consideration the detection time for a disease and the sensitivity of the test at the same time.

Despite the fact that all nucleic acid testing devices provide quick sample-to-result diagnostics, their limitation of portability may render them unaffordable for most users in settings with limited resources. The present methods for nucleic acid testing have a number of limitations, thus, impacting the demand within the market as a whole over the projected period.

2017-2022 Nucleic Acid Testing Market Outlook in Comparison to 2022-2028 Growth Forecast

Nucleic acid tests are highly sought-after in the healthcare sector owing to their ability to detect causes of infection without any previous indication. These tests can also resolve false reactive interpretations and provide an additional layer of blood screening.

Rising usage of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by a bacteria or virus is anticipated to spur their demand worldwide. Apart from this, extensive use utilized for paternity testing/HLA typing and forensic testing will aid the expansion of the nucleic acid testing market in the coming years.

These tests help healthcare professionals and researchers in narrowing down the period of infection. In other words, it reduces the window period between the time of serological detection of a virus and the time of viral exposure. Thus, the ability of these tests to deliver accurate results in the early detection process is likely to accelerate their demand in the forthcoming years.

Nucleic Acid Testing Market Download Report Brochure

Launch of Novel Test Kits with Short Turn-Around Times Propelling Nucleic Acid Testing Market Growth

Ongoing technological advancements in the healthcare industry are expected to fuel the demand for nucleic acid tests. Various manufacturers operating in this market are developing in-house capabilities to come up with premium-quality test kits with short turn-around times for meeting different research requirements.

Besides this, the high demand for state-of-the-art methods in sample amplification, extraction, and preparation is set to spur the growth of this market. The need for these test kits for the identification of RNA and DNA also is expected to augment the growth.

Leading manufacturers are collaborating with various research institutes to co-develop novel test kits and bolster research activities in the field of molecular biology. Many start-up companies are also anticipated to enter this market to create new products and meet the surging medical needs.

In December 2021, for instance, Roche, a multinational healthcare company based in Switzerland, introduced its latest infectious disease tests on a novel molecular laboratory instrument named cobas 5800 System in countries accepting the CE mark.

The new products include cobas omni Utility Channel kit, cobas HIV-1/HIV-2 Qualitative, cobas HCV, cobas HBV, and cobas HIV-1. HIV-1/HIV-2 Qualitative is an in vitro nucleic acid amplification test for the differentiation and detection of HIV-1 and HIV-2 in dried blood spots, plasma, and serum.

Such unique product launches by various key players are projected create prospects for the growth of the market in the near future. Additionally, the high demand for these kits from blood banks and blood transfusion centers is set to secure the entire blood transfusion. This is expected to emer

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

How is the U.S. Nucleic Acid Testing Market Faring?

The increasing cases of infectious diseases and the presence of a well-established healthcare infrastructure are anticipated to spur the market in the U.S. As per FMI, North America nucleic acid testing market is likely to hold 34.2% of the market share in 2022.

Besides this, the surging prevalence of cancer in the U.S. is set to drive the demand for these diagnostic tests. The American Cancer Society mentioned that in the U.S., around 1.9 million new cancer cases are expected to be diagnosed in 2021.

Apart from that, the urgent need for better diagnostic tests for the detection of hepatitis B in this country is also set to fuel the growth. As per the Centers for Disease Control and Prevention (CDC), in 2018, approximately 3,322 new cases of hepatitis B were diagnosed in the U.S.

Will China Nucleic Acid Testing Market Exhibit High Growth?

Being the epicentre of the COVID-19 pandemic, China is projected to account for the largest market share in the near future. According to the analysis of FMI, Asia Pacific excluding Japan (APECJ) nucleic acid testing market is estimated to procure about 7.4% of the market share in 2022.

The rising government initiatives to prevent the spread of the coronavirus is compelling manufacturers to produce innovative test kits in China. For instance, in December 2021, capital of northeast China's Heilongjiang Province, Harbin, conducted the third nucleic acid testing in the main urban areas. This decision was taken after two positive COVID-19 cases were detected in the second nucleic acid testing. 

How will Government Support Drive the U.K. Nucleic Acid Testing Market?

The U.K. is anticipated to be one of the most flourishing countries in the market on the back of increasing development of unique test kits by renowned manufacturers. As per FMI, Western Europe nucleic acid testing market is likely to hold about 17.0% of the market share in 2022.

The U.K. government is set to encourage the manufacturers of these tests to keep up with their production processes for meeting the high unmet needs. In November 2021, for instance, it published a Target Product Profile (TPP) which highlights updated intended-use and changes to clinical sensitivity concerning these tests. It aims to boost and support the development of innovative medical technologies to address the high demand in the U.K.

TPP can be used by manufacturers to develop laboratory-based in vitro diagnostic tests for detecting SARS-CoV-2 infection in people without or with symptoms. This is considered to be a part of the government’s accredited private testing services or national testing program.  

Category-wise Insights

Why are Sales of Nucleic Acid Test Kits Surging?

Based on product type, sales of nucleic acid test kits are expected to surge at a rapid pace during the assessment period. In 2022, the segment is anticipated to showcase 89.5% in terms of the global market share, finds FMI.

Amongst the various types of nucleic acid test kits, the demand for Polymerase Chain Reaction (PCR) is projected to skyrocket in the upcoming years. These test kits have diverse applications in DNA mapping, cloning, typing, structural analysis, mutation analysis, and disease detection.

Why is the Prevalence of Infectious Diseases Boosting Demand for Tests?

In terms of indication, infectious diseases are anticipated to surge at a fast pace in the near future because of the rising prevalence of tuberculosis and hepatitis B across the globe. As per the World Health Organization (WHO), in 2020, approximately 1.5 million people died because of tuberculosis worldwide.

Further, the recent outbreak of COVID-19 pandemic is set to drive the demand for nucleic acid tests in various parts of the world. These are considered to be very efficient for epidemic control and patient management.

Who will Remain the Dominant End User?

Based on end user, research institutes are expected to remain at the forefront in terms of market share over the forthcoming years. This dominance is attributable to the increasing number of research and development activities taking place in these institutes for the development of state-of-the-art nucleic acid testing.

In November 2021, for instance, Dutch researchers published a study in medRxiv, a preprint server, about the efficiency of nucleic acid amplification tests in the detection of SARS-CoV-2. They used pooled swab samples to compare the analytical sensitivity of different SARS-CoV-2 assays. The results showed that nucleic acid testing was more accurate than antigen assays in identifying the contagious individuals.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competition Landscape

Key players operating in the nucleic acid testing market are focusing on expanding their production capacities to cater to the high demand worldwide amid the COVID-19 pandemic. Also, the emergence of new variants of the virus is set to compel them to cut down the costs of these tests, while enhancing their efficacy. Government agencies are likely to support the manufacturing companies by providing them with funds to produce test kits and supply them across the globe.

For instance,

  • December 2021: Various cities in China reduced the prices of COVID-19 nucleic acid tests at public hospitals to provide a more affordable range during a new wave of cases. The Chinese authorities are striving to offer relatively low-cost tests to people from all financial backgrounds. The cities of Luoyang and Jiyuan lowered the price to $4.73 for a single test. For groups, they are planning to reduce it to $1.57 per person.  
  • November 2021: Chinese nucleic acid test kit manufacturers announced that they have started ramping up the production of these kits owing to the unexpected outbreak of Omicron worldwide. Sansure Biotech, for instance, stated that its employees have started working overtime to ensure the supply and production of these kits as many countries have been inquiring regarding the same. The company’s 2019-nCoV nucleic acid detection reagent is capable of detecting the new strain when used with the PCR method.

Scope of Report

Attribute

Details

Forecast Period

2017-2022

Historical Data Available for

2022-2028

Market Analysis

Units for Volume and US$ Mn for Value

Key Regions Covered

North America, Latin America, Western Europe, Eastern Europe, APECJ, and the Middle East & Africa.

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.

Key Market Segments Covered

Product Type, Indication, End-user, and Region

Key Companies Profiled

  • Agilent Technologies
  • Danaher Corporation
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen

Pricing

Available upon Request

Nucleic Acid Testing Market by Category

Product Type:

  • Nucleic Acid Test Kits
    • Transcription-Mediated Amplification (TMA)
    • Polymerase Chain Reaction (PCR)
    • Ligase Chain Reaction (LCR)
    • Whole Genome Sequencing
  • Consumables

Indication:

  • Infectious diseases
  • Cancer
  • Forensic Testing
  • Others

End-user:

  • Hospitals
  • Pathology laboratories
  • Research Institutes
  • Clinics

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • China
  • Japan
  • MEA

Frequently Asked Questions

The global nucleic acid testing market is expected to reach a valuation of US$ 3.4 Bn in 2022.

The global nucleic acid testing market grew at a healthy 7.6% CAGR between 2017 and 2022.

Increasing launch of various innovative test kits with short turn-around time by manufacturers, rising prevalence of communicable diseases, and high demand from blood banks are some key trends boosting the nucleic acid testing sales.

Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., Merck KGaA, and Qiagen are some of the leading players operating in the global nucleic acid testing market.

The nucleic acid testing market in North America is anticipated to account for 34.2% of the total market share in 2022.

Japan nucleic acid testing market is projected to account for 7.1% of the total market share in the forecast period.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Company Description and Nucleic Acid Testing Market Research Coverage

3. Nucleic Acid Testing Market Opportunity Analysis

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Global Economic Outlook

    4.1. Global Gross Domestic Product by Region & Country

    4.2. Nucleic Acid Testing Market Outlook

5. Market Background

    5.1. List of Growth Hacking Manufacturers

    5.2. Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

    5.3. Regional Pricing Analysis

6. Macroeconomic Assumptions

7. North America Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    7.1. Introduction

    7.2. Regional Market Trends

    7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        7.3.1. U.S.

        7.3.2. Canada

    7.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        7.4.1. U.S.

        7.4.2. Canada

    7.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        7.5.1. Nucleic Acid test Kits

            7.5.1.1. Transcription –mediated amplification (TMA)

            7.5.1.2. Polymerase chain reaction (PCR)

            7.5.1.3. Ligase chain reaction (LCR)

            7.5.1.4. Whole genome sequencing

        7.5.2. Consumables

    7.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    7.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        7.7.1. Infectious diseases

        7.7.2. Cancer

        7.7.3. Forensic Testing

        7.7.4. Others

    7.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        7.9.1. Hospitals

        7.9.2. Pathology laboratories

        7.9.3. Research Institutes

        7.9.4. Clinics

    7.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    7.11. Drivers and Restraints: Impact Analysis

    7.12. Market Attractiveness Analysis

        7.12.1. By Country

        7.12.2. By Product Type

        7.12.3. By Indication

        7.12.4. By End user

    7.13. Key Market Participants – Intensity Mapping

    7.14. Key Mergers & Acquisitions

8. Western Europe Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    8.1. Introduction

    8.2. Regional Market Trends

    8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        8.3.1. Germany

        8.3.2. U.K

        8.3.3. France

        8.3.4. Italy

        8.3.5. Spain

        8.3.6. Rest of Western Europe

    8.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        8.4.1. Germany

        8.4.2. U.K

        8.4.3. France

        8.4.4. Italy

        8.4.5. Spain

        8.4.6. Rest of Western Europe

    8.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        8.5.1. Nucleic Acid test Kits

            8.5.1.1. Transcription –mediated amplification (TMA)

            8.5.1.2. Polymerase chain reaction (PCR)

            8.5.1.3. Ligase chain reaction (LCR)

            8.5.1.4. Whole genome sequencing

        8.5.2. Consumables

    8.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    8.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        8.7.1. Infectious diseases

        8.7.2. Cancer

        8.7.3. Forensic Testing

        8.7.4. Others

    8.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        8.9.1. Hospitals

        8.9.2. Pathology laboratories

        8.9.3. Research Institutes

        8.9.4. Clinics

    8.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    8.11. Drivers and Restraints: Impact Analysis

    8.12. Market Attractiveness Analysis

        8.12.1. By Country

        8.12.2. By Product Type

        8.12.3. By Indication

        8.12.4. By End user

    8.13. Key Market Participants – Intensity Mapping

    8.14. Key Mergers & Acquisitions

9. Eastern Europe Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    9.1. Introduction

    9.2. Regional Market Trends

    9.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        9.3.1. Russia

        9.3.2. Poland

        9.3.3. Rest of Eastern Europe

    9.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        9.4.1. Russia

        9.4.2. Poland

        9.4.3. Rest of Eastern Europe

    9.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        9.5.1. Nucleic Acid test Kits

            9.5.1.1. Transcription –mediated amplification (TMA)

            9.5.1.2. Polymerase chain reaction (PCR)

            9.5.1.3. Ligase chain reaction (LCR)

            9.5.1.4. Whole genome sequencing

        9.5.2. Consumables

    9.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    9.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        9.7.1. Infectious diseases

        9.7.2. Cancer

        9.7.3. Forensic Testing

        9.7.4. Others

    9.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        9.9.1. Hospitals

        9.9.2. Pathology laboratories

        9.9.3. Research Institutes

        9.9.4. Clinics

    9.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    9.11. Drivers and Restraints: Impact Analysis

    9.12. Market Attractiveness Analysis

        9.12.1. By Country

        9.12.2. By Product Type

        9.12.3. By Indication

        9.12.4. By End user

    9.13. Key Market Participants – Intensity Mapping

    9.14. Key Mergers & Acquisitions

10. Latin America Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    10.1. Introduction

    10.2. Regional Market Trends

    10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        10.3.1. Brazil

        10.3.2. Mexico

        10.3.3. Rest of Latin America

    10.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        10.4.1. Brazil

        10.4.2. Mexico

        10.4.3. Rest of Latin America

    10.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        10.5.1. Nucleic Acid test Kits

            10.5.1.1. Transcription –mediated amplification (TMA)

            10.5.1.2. Polymerase chain reaction (PCR)

            10.5.1.3. Ligase chain reaction (LCR)

            10.5.1.4. Whole genome sequencing

        10.5.2. Consumables

    10.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    10.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        10.7.1. Infectious diseases

        10.7.2. Cancer

        10.7.3. Forensic Testing

        10.7.4. Others

    10.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        10.9.1. Hospitals

        10.9.2. Pathology laboratories

        10.9.3. Research Institutes

        10.9.4. Clinics

    10.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    10.11. Drivers and Restraints: Impact Analysis

    10.12. Market Attractiveness Analysis

        10.12.1. By Country

        10.12.2. By Product Type

        10.12.3. By Indication

        10.12.4. By End user

    10.13. Key Market Participants – Intensity Mapping

    10.14. Key Mergers & Acquisitions

11. Asia Pacific Excluding China & Japan Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    11.1. Introduction

    11.2. Regional Market Trends

    11.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        11.3.1. India

        11.3.2. Australia and New Zealand

        11.3.3. ASEAN

        11.3.4. Rest of APECJ

    11.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        11.4.1. India

        11.4.2. Australia and New Zealand

        11.4.3. ASEAN

        11.4.4. Rest of APECJ

    11.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        11.5.1. Nucleic Acid test Kits

            11.5.1.1. Transcription –mediated amplification (TMA)

            11.5.1.2. Polymerase chain reaction (PCR)

            11.5.1.3. Ligase chain reaction (LCR)

            11.5.1.4. Whole genome sequencing

        11.5.2. Consumables

    11.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    11.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        11.7.1. Infectious diseases

        11.7.2. Cancer

        11.7.3. Forensic Testing

        11.7.4. Others

    11.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        11.9.1. Hospitals

        11.9.2. Pathology laboratories

        11.9.3. Research Institutes

        11.9.4. Clinics

    11.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    11.11. Drivers and Restraints: Impact Analysis

    11.12. Market Attractiveness Analysis

        11.12.1. By Country

        11.12.2. By Product Type

        11.12.3. By Indication

        11.12.4. By End user

    11.13. Key Market Participants – Intensity Mapping

    11.14. Key Mergers & Acquisitions

12. China Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    12.1. Introduction

    12.2. Market Trends

    12.3. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        12.3.1. Nucleic Acid test Kits

            12.3.1.1. Transcription –mediated amplification (TMA)

            12.3.1.2. Polymerase chain reaction (PCR)

            12.3.1.3. Ligase chain reaction (LCR)

            12.3.1.4. Whole genome sequencing

        12.3.2. Consumables

    12.4. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    12.5. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        12.5.1. Infectious diseases

        12.5.2. Cancer

        12.5.3. Forensic Testing

        12.5.4. Others

    12.6. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        12.7.1. Hospitals

        12.7.2. Pathology laboratories

        12.7.3. Research Institutes

        12.7.4. Clinics

    12.8. Market Size (US$ Mn) Forecast By End User, 2022-2028

    12.9. Drivers and Restraints: Impact Analysis

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Product Type

        12.10.3. By Indication

        12.10.4. By End user

    12.11. Key Market Participants – Intensity Mapping

    12.12. Key Mergers & Acquisitions

13. Japan Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    13.1. Introduction

    13.2. Market Trends

    13.3. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        13.3.1. Nucleic Acid test Kits

            13.3.1.1. Transcription –mediated amplification (TMA)

            13.3.1.2. Polymerase chain reaction (PCR)

            13.3.1.3. Ligase chain reaction (LCR)

            13.3.1.4. Whole genome sequencing

        13.3.2. Consumables

    13.4. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    13.5. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        13.5.1. Infectious diseases

        13.5.2. Cancer

        13.5.3. Forensic Testing

        13.5.4. Others

    13.6. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        13.7.1. Hospitals

        13.7.2. Pathology laboratories

        13.7.3. Research Institutes

        13.7.4. Clinics

    13.8. Market Size (US$ Mn) Forecast By End User, 2022-2028

    13.9. Drivers and Restraints: Impact Analysis

    13.10. Market Attractiveness Analysis

        13.10.1. By Country

        13.10.2. By Product Type

        13.10.3. By Indication

        13.10.4. By End user

    13.11. Key Market Participants – Intensity Mapping

    13.12. Key Mergers & Acquisitions

14. Middle East and Africa Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    14.1. Introduction

    14.2. Regional Market Trends

    14.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        14.3.1. GCC Countries

        14.3.2. South Africa

        14.3.3. Rest of Middle East and Africa

    14.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        14.4.1. GCC Countries

        14.4.2. South Africa

        14.4.3. Rest of Middle East and Africa

    14.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2021

        14.5.1. Nucleic Acid test Kits

            14.5.1.1. Transcription –mediated amplification (TMA)

            14.5.1.2. Polymerase chain reaction (PCR)

            14.5.1.3. Ligase chain reaction (LCR)

            14.5.1.4. Whole genome sequencing

        14.5.2. Consumables

    14.6. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    14.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        14.7.1. Infectious diseases

        14.7.2. Cancer

        14.7.3. Forensic Testing

        14.7.4. Others

    14.8. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    14.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        14.9.1. Hospitals

        14.9.2. Pathology laboratories

        14.9.3. Research Institutes

        14.9.4. Clinics

    14.10. Market Size (US$ Mn) Forecast By End User, 2022-2028

    14.11. Drivers and Restraints: Impact Analysis

    14.12. Market Attractiveness Analysis

        14.12.1. By Country

        14.12.2. By Product Type

        14.12.3. By Indication

        14.12.4. By End user

    14.13. Key Market Participants – Intensity Mapping

    14.14. Key Mergers & Acquisitions

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

    17.1. Market Structure by Tier of Companies

    17.2. Market Share Analysis (2021) for Top 10 Players, By Region

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Profitability and Gross Margin Analysis By Competition

    18.3. Company Deep Dive

        18.3.1. Agilent Technologies

            18.3.1.1. Overview

            18.3.1.2. Product and Application Portfolio

            18.3.1.3. Production Footprint

            18.3.1.4. Sales Footprint

            18.3.1.5. Channel Footprint

            18.3.1.6. Strategy

                18.3.1.6.1. Marketing Strategy

                18.3.1.6.2. Product Strategy

                18.3.1.6.3. Channel Strategy

        18.3.2. Danaher Corporation

            18.3.2.1. Overview

            18.3.2.2. Product and Application Portfolio

            18.3.2.3. Production Footprint

            18.3.2.4. Sales Footprint

            18.3.2.5. Channel Footprint

            18.3.2.6. Strategy

                18.3.2.6.1. Marketing Strategy

                18.3.2.6.2. Product Strategy

                18.3.2.6.3. Channel Strategy

        18.3.3. Abbott Laboratories, Inc.

            18.3.3.1. Overview

            18.3.3.2. Product and Application Portfolio

            18.3.3.3. Production Footprint

            18.3.3.4. Sales Footprint

            18.3.3.5. Channel Footprint

            18.3.3.6. Strategy

                18.3.3.6.1. Marketing Strategy

                18.3.3.6.2. Product Strategy

                18.3.3.6.3. Channel Strategy

        18.3.4. Becton, Dickinson and Company

            18.3.4.1. Overview

            18.3.4.2. Product and Application Portfolio

            18.3.4.3. Production Footprint

            18.3.4.4. Sales Footprint

            18.3.4.5. Channel Footprint

            18.3.4.6. Strategy

                18.3.4.6.1. Marketing Strategy

                18.3.4.6.2. Product Strategy

                18.3.4.6.3. Channel Strategy

        18.3.5. Bio-Rad Laboratories, Inc.

            18.3.5.1. Overview

            18.3.5.2. Product and Application Portfolio

            18.3.5.3. Production Footprint

            18.3.5.4. Sales Footprint

            18.3.5.5. Channel Footprint

            18.3.5.6. Strategy

                18.3.5.6.1. Marketing Strategy

                18.3.5.6.2. Product Strategy

                18.3.5.6.3. Channel Strategy

        18.3.6. F. Hoffmann-La Roche Ltd.

            18.3.6.1. Overview

            18.3.6.2. Product and Application Portfolio

            18.3.6.3. Production Footprint

            18.3.6.4. Sales Footprint

            18.3.6.5. Channel Footprint

            18.3.6.6. Strategy

                18.3.6.6.1. Marketing Strategy

                18.3.6.6.2. Product Strategy

                18.3.6.6.3. Channel Strategy

        18.3.7. Illumina, Inc.

            18.3.7.1. Overview

            18.3.7.2. Product and Application Portfolio

            18.3.7.3. Production Footprint

            18.3.7.4. Sales Footprint

            18.3.7.5. Channel Footprint

            18.3.7.6. Strategy

                18.3.7.6.1. Marketing Strategy

                18.3.7.6.2. Product Strategy

                18.3.7.6.3. Channel Strategy

        18.3.8. Thermo Fisher Scientific Inc.

            18.3.8.1. Overview

            18.3.8.2. Product and Application Portfolio

            18.3.8.3. Production Footprint

            18.3.8.4. Sales Footprint

            18.3.8.5. Channel Footprint

            18.3.8.6. Strategy

                18.3.8.6.1. Marketing Strategy

                18.3.8.6.2. Product Strategy

                18.3.8.6.3. Channel Strategy

        18.3.9. Merck KGaA,

            18.3.9.1. Overview

            18.3.9.2. Product and Application Portfolio

            18.3.9.3. Production Footprint

            18.3.9.4. Sales Footprint

            18.3.9.5. Channel Footprint

            18.3.9.6. Strategy

                18.3.9.6.1. Marketing Strategy

                18.3.9.6.2. Product Strategy

                18.3.9.6.3. Channel Strategy

        18.3.10. Qiagen

            18.3.10.1. Overview

            18.3.10.2. Product and Application Portfolio

            18.3.10.3. Production Footprint

            18.3.10.4. Sales Footprint

            18.3.10.5. Channel Footprint

            18.3.10.6. Strategy

                18.3.10.6.1. Marketing Strategy

                18.3.10.6.2. Product Strategy

                18.3.10.6.3. Channel Strategy

19. Global Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028 By Region

    19.1. Introduction / Key Findings

    19.2. Historical Market Size (US$ Mn) Analysis By Region

        19.2.1. North America

        19.2.2. Western Europe

        19.2.3. Eastern Europe

        19.2.4. Latin America

        19.2.5. Asia Pacific Excluding Japan

        19.2.6. Japan

        19.2.7. Middle East and Africa

    19.3. Market Size (US$ Mn) Forecast By Region

        19.3.1. North America

        19.3.2. Western Europe

        19.3.3. Eastern Europe

        19.3.4. Latin America

        19.3.5. Asia Pacific Excluding Japan

        19.3.6. Japan

        19.3.7. Middle East and Africa

    19.4. Market Attractiveness Analysis By Region

20. Global Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028, By Product Type

    20.1. Introduction/Key Finding

    20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type , 2012-2021

        20.2.1. Nucleic Acid test Kits

            20.2.1.1. Transcription –mediated amplification (TMA)

            20.2.1.2. Polymerase chain reaction (PCR)

            20.2.1.3. Ligase chain reaction (LCR)

            20.2.1.4. Nucleic acid sequence –based amplification.

            20.2.1.5. Whole genome sequencing

        20.2.2. Consumables

    20.3. Market Size (US$ Mn) Forecast By Product Type , 2022-2028

    20.4. Market Attractiveness Analysis By Product Type

21. Global Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028, By Indication

    21.1. Introduction/Key Finding

    21.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2021

        21.2.1. Infectious diseases

        21.2.2. Cancer

        21.2.3. Forensic Testing

        21.2.4. Paternity Testing/HLA Typing

        21.2.5. Others

    21.3. Market Size (US$ Mn) Forecast By Indication, 2022-2028

    21.4. Market Attractiveness Analysis By Indication

22. Global Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028, By End User

    22.1. Introduction/Key Finding

    22.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2021

        22.2.1. Hospitals

        22.2.2. Pathology laboratories

        22.2.3. Research Institutes

        22.2.4. Clinics

    22.3. Market Size (US$ Mn) Forecast By End User, 2022-2028

    22.4. Market Attractiveness Analysis By End User

23. Global Nucleic Acid Testing Market Analysis 2012–2021 and Forecast 2022-2028

    23.1. Market Value Share Analysis

        23.1.1. By Product Type

        23.1.2. By Indication

        23.1.3. By End user

    23.2. Y-o-Y Growth Analysis

        23.2.1. By Product Type

        23.2.2. By Indication

        23.2.3. By End user

    23.3. Absolute $ Opportunity

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 02: North America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 03: North America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 04: North America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 05: Latin America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 06: Latin America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 07: Latin America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 08: Latin America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 09: Western Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 10: Western Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 11: Western Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 12: Western Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 13: Eastern Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 14: Eastern Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 15: Eastern Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 16: Eastern Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 17: APECJ Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 18: APECJ Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 19: APECJ Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 20: APECJ Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 21: China Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 22: China Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 23: China Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 24: Japan Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 25: Japan Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 26: Japan Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 27: MEA Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Country

Table 28: MEA Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 29: MEA Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 30: MEA Nucleic Acid Testing Market Size (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Table 31: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Region

Table 32: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Product Type

Table 33: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By Indication

Table 34: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2013-2021 and Forecast 2022-2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Nucleic Acid Testing Market Value Share By Product Type 2021(A)

Figure 02: Global Nucleic Acid Testing Market Value (US$ Mn) By Indication, 2021(A)

Figure 03: Global Nucleic Acid Testing Market Value Share By End User, 2021(A)

Figure 04: Global Nucleic Acid Testing Market Value Share By Region, 2021(A)

Figure 05: Nucleic Acid Testing kit, Price Difference (US$) By Region, 2016

Figure 06: Nucleic Acid Testing kit, Price Difference (US$) By Region, 2027

Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2021)

Figure 08: North America Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 09: North America Nucleic Acid Testing Market Forecast, 2022-2028

Figure 10: U.S. Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 11: U.S. Nucleic Acid Testing Market Forecast, 2022-2028

Figure 12: Canada Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 13: Canada Nucleic Acid Testing Market Forecast, 2022-2028

Figure 14: North America Nucleic Acid Testing Market Size (US$) Analysis, By Nucleic Acid test Kits, 2013-2021

Figure 15: North America Nucleic Acid Testing Market Forecast, By Nucleic Acid test Kits, 2022-2028

Figure 16: North America Nucleic Acid Testing Market Size Analysis, By Consumables ,2013-2021

Figure 17: North America Nucleic Acid Testing Market Forecast, By Consumables, 2022-2028

Figure 18: North America Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2013-2021

Figure 19: North America Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2022-2028

Figure 20: North America Nucleic Acid Testing Market Size Analysis, By Cancer ,2013-2021

Figure 21: North America Nucleic Acid Testing Market Forecast, By Cancer, 2022-2028

Figure 22: North America Nucleic Acid Testing Market Size Analysis, By Forensic Testing 2013-2021

Figure 23: North America Nucleic Acid Testing Market Forecast, By Forensic Testing, 2022-2028

Figure 24: North America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2013-2021

Figure 25: North America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2022-2028

Figure 26: North America Nucleic Acid Testing Market Size Analysis, By Hospitals, 2013-2021

Figure 27: North America Nucleic Acid Testing Market Forecast, By Hospitals, 2022-2028

Figure 28: North America Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2013-2021

Figure 29: North America Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2022-2028

Figure 30: North America Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2013-2021

Figure 31: North America Nucleic Acid Testing Market Forecast, By Research Institutes, 2022-2028

Figure 32: North America Nucleic Acid Testing Market Size Analysis, By Clinics, 2013-2021

Figure 33: North America Nucleic Acid Testing Market Forecast, By Clinics, 2022-2028

Figure 34: North America Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 35: North Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 36: North Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 37: North Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 38: Latin America Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 39: Latin America Nucleic Acid Testing Market Forecast, 2022-2028

Figure 40: Brazil Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 41: Brazil Nucleic Acid Testing Market Forecast, 2022-2028

Figure 42: Mexico Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 43: Mexico Nucleic Acid Testing Market Forecast, 2022-2028

Figure 44: Rest of Latin America Centers Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 45: Rest of Latin America Centers Nucleic Acid Testing Market Size Analysis, 2022-2028

Figure 46: Latin America Nucleic Acid Testing Market Size Analysis, By Nucleic Acid test Kits, 2013-2021

Figure 47: Latin America Nucleic Acid Testing Market Forecast, By Nucleic Acid test Kits, 2022-2028

Figure 48: Latin America Nucleic Acid Testing Market Size Analysis, By Consumables, 2013-2021

Figure 49: Latin America Nucleic Acid Testing Market Forecast, By Consumables, 2022-2028

Figure 50: Latin America Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2013-2021

Figure 51: Latin America Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2022-2028

Figure 52: Latin America Nucleic Acid Testing Market Size Analysis, By Cancer, 2013-2021

Figure 53: Latin America Nucleic Acid Testing Market Forecast, By Cancer, 2022-2028

Figure 54: Latin America Nucleic Acid Testing Market Size Analysis, By Forensic Testing, 2013-2021

Figure 55: Latin America Nucleic Acid Testing Market Forecast, By Forensic Testing, 2022-2028

Figure 56: Latin America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2013-2021

Figure 57: Latin America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2022-2028

Figure 58: Latin America Nucleic Acid Testing Market Size Analysis, By Hospitals, 2013-2021

Figure 59: Latin America Nucleic Acid Testing Market Forecast, By Hospitals, 2022-2028

Figure 60: Latin America Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2013-2021

Figure 61: Latin America Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2022-2028

Figure 62: Latin America Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2013-2021

Figure 63: Latin America Nucleic Acid Testing Market Forecast, By Research Institutes, 2022-2028

Figure 64: Latin America Nucleic Acid Testing Market Size Analysis, By Clinics, 2013-2021

Figure 65: Latin America Nucleic Acid Testing Market Forecast, By Clinics, 2022-2028

Figure 66: Latin America Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 67: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 68: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 69: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 70: Western Europe Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 71: Western Europe Nucleic Acid Testing Market Forecast, 2022-2028

Figure 72: Germany Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 73: Germany Nucleic Acid Testing Market Forecast, 2022-2028

Figure 74: U.K. Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 75: U.K. Nucleic Acid Testing Market Forecast, 2022-2028

Figure 76: France Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 77: France Nucleic Acid Testing Market Forecast, 2022-2028

Figure 78: Italy Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 79: Italy Nucleic Acid Testing Market Forecast, 2022-2028

Figure 80: Spain Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 81: Spain Nucleic Acid Testing Market Forecast, 2022-2028

Figure 82: Rest of Western Europe Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 83: Rest of Western Europe Nucleic Acid Testing Market Forecast, 2022-2028

Figure 84: Western Europe Nucleic Acid Testing Market Size Analysis by Nucleic Acid test Kits, 2013-2021

Figure 85: Western Europe Nucleic Acid Testing Market Forecast by Nucleic Acid test Kits, 2022-2028

Figure 86: Western Europe Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 87: Western Europe Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 88: Western Europe Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2013-2021

Figure 89: Western Europe Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2022-2028

Figure 90: Western Europe Nucleic Acid Testing Market Size Analysis, By Cancer ,2013-2021

Figure 91: Western Europe Nucleic Acid Testing Market Forecast, By Cancer, 2022-2028

Figure 92: Western Europe Nucleic Acid Testing Market Size Analysis, By Forensic Testing 2013-2021

Figure 93: Western Europe Nucleic Acid Testing Market Forecast, By Forensic Testing, 2022-2028

Figure 94: Western Europe Nucleic Acid Testing Market Size Analysis, By Other Indications, 2013-2021

Figure 95: Western Europe Nucleic Acid Testing Market Size Analysis, By Other Indications, 2013-2021

Figure 96: Western Europe Nucleic Acid Testing Market Size Analysis, By Hospitals, 2013-2021

Figure 97: Western Europe Nucleic Acid Testing Market Forecast, By Hospitals, 2022-2028

Figure 98: Western Europe Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2013-2021

Figure 99: Western Europe Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2022-2028

Figure 100: Western Europe Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2013-2021

Figure 101: Western Europe Nucleic Acid Testing Market Forecast, By Research Institutes, 2022-2028

Figure 102: Western Europe Nucleic Acid Testing Market Size Analysis, By Clinics, 2013-2021

Figure 103: Western Europe Nucleic Acid Testing Market Forecast, By Clinics, 2022-2028

Figure 104: Western Europe Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 105: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 106: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 107: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 108: Eastern Europe Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 109: Eastern Europe Nucleic Acid Testing Market Forecast, 2022-2028

Figure 110: Russia Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 111: Russia Nucleic Acid Testing Market Forecast, 2022-2028

Figure 112: Poland Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 113: Poland Nucleic Acid Testing Market Forecast, 2022-2028

Figure 114: Rest of Eastern Europe Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 115: Rest of Eastern Europe Nucleic Acid Testing Market Size Analysis, 2022-2028

Figure 116: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2013-2021

Figure 117: Eastern Europe Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2022-2028

Figure 118: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 119: Eastern Europe Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 120: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2013-2021

Figure 121: Eastern Europe Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2022-2028

Figure 122: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Cancer, 2013-2021

Figure 123: Eastern Europe Nucleic Acid Testing Market Forecast, by Cancer, 2022-2028

Figure 124: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2013-2021

Figure 125: Eastern Europe Nucleic Acid Testing Market Forecast, by Forensic Testing, 2022-2028

Figure 126: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Others Indications, 2013-2021

Figure 127: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Others Indications, 2022-2028

Figure 128: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Hospitals, 2013-2021

Figure 129: Eastern Europe Nucleic Acid Testing Market Forecast, by Hospitals, 2022-2028

Figure 130: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2013-2021

Figure 131: Eastern Europe Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2022-2028

Figure 132: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2013-2021

Figure 133: Eastern Europe Nucleic Acid Testing Market Forecast, by Research Institutes, 2022-2028

Figure 134: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Clinics, 2013-2021

Figure 135: Eastern Europe Nucleic Acid Testing Market Forecast, by Clinics, 2022-2028

Figure 136: Eastern Europe Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 137: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 138: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 139: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 140: APECJ Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 141: APECJ Nucleic Acid Testing Market Forecast, 2022-2028

Figure 142: India Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 143: India Nucleic Acid Testing Market Forecast, 2022-2028

Figure 144: Australia & New Zealand Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 145: Australia & New Zealand Nucleic Acid Testing Market Forecast, 2022-2028

Figure 146: ASEAN Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 147: ASEAN Nucleic Acid Testing Market Forecast, 2022-2028

Figure 148: Rest of APECJ Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 149: Rest of APECJ Nucleic Acid Testing Market Forecast, 2022-2028

Figure 150: APECJ Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2013-2021

Figure 151: APECJ Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2022-2028

Figure 152: APECJ Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 153: APECJ Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 154: APECJ Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2013-2021

Figure 155: APECJ Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2022-2028

Figure 156: APECJ Nucleic Acid Testing Market Size Analysis, by Cancer, 2013-2021

Figure 157: APECJ Nucleic Acid Testing Market Forecast, by Cancer, 2022-2028

Figure 158: APECJ Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2013-2021

Figure 159: APECJ Nucleic Acid Testing Market Forecast, by Forensic Testing, 2022-2028

Figure 160: APECJ Nucleic Acid Testing Market Size Analysis, Other Indication, 2013-2021

Figure 161: APECJ Nucleic Acid Testing Market Size Analysis, by Other Indication, 2022-2028

Figure 162: APECJ Nucleic Acid Testing Market Size Analysis, by Hospitals, 2013-2021

Figure 163: APECJ Nucleic Acid Testing Market Forecast, by Hospitals, 2022-2028

Figure 164: APECJ Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2013-2021

Figure 165: APECJ Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2022-2028

Figure 166: APECJ Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2013-2021

Figure 167: APECJ Nucleic Acid Testing Market Forecast, by Research Institutes, 2022-2028

Figure 168: APECJ Nucleic Acid Testing Market Size Analysis, by Clinics, 2013-2021

Figure 169: APECJ Nucleic Acid Testing Market Forecast, by Clinics, 2022-2028

Figure 170: APECJ Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 171: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 172: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 173: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 174: China Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 175: China Nucleic Acid Testing Market Forecast, 2022-2028

Figure 176: China Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2013-2021

Figure 177: China Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2022-2028

Figure 178: China Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 179: China Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 180: China Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2013-2021

Figure 181: China Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2022-2028

Figure 182: China Nucleic Acid Testing Market Size Analysis, by Cancer, 2013-2021

Figure 183: China Nucleic Acid Testing Market Forecast, by Cancer, 2022-2028

Figure 184: China Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2013-2021

Figure 185: China Nucleic Acid Testing Market Forecast, by Forensic Testing, 2022-2028

Figure 186: China Nucleic Acid Testing Market Size Analysis, by Others Indications, 2013-2021

Figure 187: China Nucleic Acid Testing Market Size Analysis, by Others Indications, 2022-2028

Figure 188: China Nucleic Acid Testing Market Size Analysis, by Hospitals, 2013-2021

Figure 189: China Nucleic Acid Testing Market Forecast, by Hospitals, 2022-2028

Figure 190: China Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2013-2021

Figure 191: China Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2022-2028

Figure 192: China Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2013-2021

Figure 193: China Nucleic Acid Testing Market Forecast, by Research Institutes, 2022-2028

Figure 194: China Nucleic Acid Testing Market Size Analysis, by Clinics, 2013-2021

Figure 195: China Nucleic Acid Testing Market Forecast, by Clinics, 2022-2028

Figure 196: China Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 197: China Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 198: China Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 199: Japan Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 200: Japan Nucleic Acid Testing Market Forecast, 2022-2028

Figure 201: Japan Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2013-2021

Figure 202: Japan Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2022-2028

Figure 203: Japan Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 204: Japan Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 205: Japan Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2013-2021

Figure 206: Japan Nucleic Acid Testing Market Forecast, Infectious Diseases, 2022-2028

Figure 207: Japan Nucleic Acid Testing Market Size Analysis, by Cancer, 2013-2021

Figure 208: Japan Nucleic Acid Testing Market Forecast, by Cancer, 2022-2028

Figure 209: Japan Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2013-2021

Figure 210: Japan Nucleic Acid Testing Market Forecast, by Forensic Testing, 2022-2028

Figure 211: Japan Nucleic Acid Testing Market Size Analysis, by Others Indications, 2013-2021

Figure 212: Japan Nucleic Acid Testing Market Size Analysis, by Others Indications, 2022-2028

Figure 213: Japan Nucleic Acid Testing Market Size Analysis, by Hospitals, 2013-2021

Figure 214: Japan Nucleic Acid Testing Market Forecast, by Hospitals, 2022-2028

Figure 215: Japan Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2013-2021

Figure 216: Japan Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2022-2028

Figure 217: Japan Nucleic Acid Testing Market Size Analysis, by y Research Institutes, 2013-2021

Figure 218: Japan Nucleic Acid Testing Market Forecast, by Research Institutes, 2022-2028

Figure 219: Japan Nucleic Acid Testing Market Size Analysis, by Clinics, 2013-2021

Figure 220: Japan Nucleic Acid Testing Market Forecast, by Clinics, 2022-2028

Figure 221: Japan Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 222: Japan Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 223: Japan Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 224: MEA Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 225: MEA Nucleic Acid Testing Market Forecast, 2022-2028

Figure 226: GCC Countries Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 227: GCC Countries Nucleic Acid Testing Market Forecast, 2022-2028

Figure 228: South Africa Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 229: South Africa Nucleic Acid Testing Market Forecast, 2022-2028

Figure 230: Rest of MEA Nucleic Acid Testing Market Size Analysis, 2013-2021

Figure 231: Rest of MEA Nucleic Acid Testing Market Size Analysis, 2022-2028

Figure 232: MEA Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2013-2021

Figure 233: MEA Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2022-2028

Figure 234: MEA Nucleic Acid Testing Market Size Analysis, by Consumables, 2013-2021

Figure 235: MEA Nucleic Acid Testing Market Forecast, by Consumables, 2022-2028

Figure 236: MEA Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2013-2021

Figure 237: MEA Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2022-2028

Figure 238: MEA Nucleic Acid Testing Market Size Analysis, by Cancer, 2013-2021

Figure 239: MEA Nucleic Acid Testing Market Forecast, by Cancer, 2022-2028

Figure 240: MEA Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2013-2021

Figure 241: MEA Nucleic Acid Testing Market Forecast, by Forensic Testing, 2022-2028

Figure 242: MEA Nucleic Acid Testing Market Size Analysis, by Others Indications, 2013-2021

Figure 243: MEA Nucleic Acid Testing Market Size Analysis, by Others Indications, 2022-2028

Figure 244: MEA Nucleic Acid Testing Market Size Analysis, by Hospitals, 2013-2021

Figure 245: MEA Nucleic Acid Testing Market Forecast, by Hospitals, 2022-2028

Figure 246: MEA Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2013-2021

Figure 247: MEA Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2022-2028

Figure 248: MEA Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2013-2021

Figure 249: MEA Nucleic Acid Testing Market Forecast, by Research Institutes, 2022-2028

Figure 250: MEA Nucleic Acid Testing Market Size Analysis, by Clinics, 2013-2021

Figure 251: MEA Nucleic Acid Testing Market Forecast, by Clinics, 2022-2028

Figure 252: MEA Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 253: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 254: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 255: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 256: Global Nucleic Acid Testing Market Attractiveness Analysis By Region, 2022-2028

Figure 257: Global Nucleic Acid Testing Market Attractiveness Analysis By Product Type, 2022-2028

Figure 258: Global Nucleic Acid Testing Market Attractiveness Analysis By Indication, 2022-2028

Figure 259: Global Nucleic Acid Testing Market Attractiveness Analysis By End User, 2022-2028

Figure 260: Global Nucleic Acid Testing Market Value Analysis and Forecast, 2022-2028 (US$ Mn)

Figure 261: Global Nucleic Acid Testing Market Absolute $ Opportunity (US$ Mn), 2013-2021

Figure 262: Global Nucleic Acid Testing Market Absolute $ Opportunity (US$ Mn), 2022-2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Adiponectin Testing Market

Published : October 2019

Healthcare

Apoptosis Testing Market

Published : September 2018

Healthcare

Mono Rapid Testing Market

Published : November 2017

Healthcare

Retrovirus Testing Market

Published : October 2017

Google translate

Nucleic Acid Testing Market